Studies and clinical trials have demonstrated the efficacy of ramipril in reducing blood pressure and preventing cardiovascular events. The Heart Outcomes Prevention Evaluation (HOPE) study is one such landmark trial that provided robust evidence supporting the use of ramipril in high-risk populations. The findings showed that ramipril significantly reduced the rates of myocardial infarction, stroke, and cardiovascular death.